完美是好的敌人吗?权衡双参数MRI用于前列腺癌的证据
本文综述了双参数MRI(省略增强序列的简化方案)用于活检前检测和表征临床显著前列腺癌的文献,讨论其优缺点并进行概念性成本/效益分析,以评估在广泛采用多参数MRI仍面临检查时长和成本挑战的背景下,双参数MRI能否作为替代方案。
要点
- 双参数MRI省略增强序列,可缩短检查时长并降低成本,有助于解决多参数MRI广泛采用的障碍。
- 综述汇总已发表文献,权衡双参数MRI用于活检前检测临床显著前列腺癌的优缺点。
- 文中提出关于采用双参数MRI的概念性成本/效益分析框架。
核心结论
- 双参数MRI可能有助于解决多参数MRI在检查时长和成本方面的挑战,但需权衡其用于活检前检测临床显著前列腺癌的优缺点,并考虑成本/效益。
研究设计与样本
- 综述,检索并汇总已发表的关于双参数MRI用于活检前检测和表征临床显著前列腺癌的文献,并进行概念性成本/效益分析。
临床应用与阅片要点
- 作者在综述中讨论双参数MRI用于活检前检测临床显著前列腺癌的合理性,并权衡其优缺点及成本/效益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The role of multiparametric MRI in diagnosis, staging and treatment planning for prostate cancer is well established. However, there remain several challenges to widespread adoption. One such challenge is the duration and cost of the examination. Abbreviated exams omitting contrast-enhanced sequences may help address this challenge. In this review, we will discuss the rationale for biparametric MRI for detection and characterization of clinically significant prostate cancer prior to biopsy and synthesize the published literature. We will weigh up the advantages and disadvantages to this approach and lay out a conceptual cost/benefit analysis regarding adoption of biparametric MRI.
引用
- Cole, Langbein, Giganti, et al. Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer. Br J Radiol. 2021. PMID: 34826223. doi:10.1259/bjr.20210840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。